ADIPOQ and type 2 diabetes mellitus: Increases in adiponectin cause a decrease in hepatic fat; adiponectin, as already mentioned, is important for drawing back the alteration in hepatic/muscle insulin resistance and in hepatic fat mobilization patients affected by T2DM [42].